Feldman BM - Search Results

1

Methods for analyzing observational longitudinal prognosis studies for rheumatic diseases: a review & worked example using a clinic-based cohort of juvenile dermatomyositis patients.

Lim LS, Pullenayegum E, Moineddin R, Gladman DD, Silverman ED, Feldman BM. Lim LS, et al. Among authors: feldman bm. Pediatr Rheumatol Online J. 2017 Mar 29;15(1):18. doi: 10.1186/s12969-017-0148-2. Pediatr Rheumatol Online J. 2017. PMID: 28356102 Free PMC article. Review.

2

Risk factors for damage in childhood-onset systemic lupus erythematosus: cumulative disease activity and medication use predict disease damage.

Brunner HI, Silverman ED, To T, Bombardier C, Feldman BM. Brunner HI, et al. Among authors: feldman bm. Arthritis Rheum. 2002 Feb;46(2):436-44. doi: 10.1002/art.10072. Arthritis Rheum. 2002. PMID: 11840446 Free article.

3

Differences in the profiles of circulating levels of soluble tumor necrosis factor receptors and interleukin 1 receptor antagonist reflect the heterogeneity of the subgroups of juvenile rheumatoid arthritis.

Muzaffer MA, Dayer JM, Feldman BM, Pruzanski W, Roux-Lombard P, Schneider R, Laxer RM, Silverman ED. Muzaffer MA, et al. Among authors: feldman bm. J Rheumatol. 2002 May;29(5):1071-8. J Rheumatol. 2002. PMID: 12022325

4

Item weightings for the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Disease Damage Index using Rasch analysis do not lead to an important improvement.

Brunner HI, Feldman BM, Urowitz MB, Gladman DD. Brunner HI, et al. Among authors: feldman bm. J Rheumatol. 2003 Feb;30(2):292-7. J Rheumatol. 2003. PMID: 12563683

5

European Consensus Lupus Activity Measurement is sensitive to change in disease activity in childhood-onset systemic lupus erythematosus.

Brunner HI, Silverman ED, Bombardier C, Feldman BM. Brunner HI, et al. Among authors: feldman bm. Arthritis Rheum. 2003 Jun 15;49(3):335-41. doi: 10.1002/art.11111. Arthritis Rheum. 2003. PMID: 12794788 Free article.

6

Preliminary core sets of measures for disease activity and damage assessment in juvenile systemic lupus erythematosus and juvenile dermatomyositis.

Ruperto N, Ravelli A, Murray KJ, Lovell DJ, Andersson-Gare B, Feldman BM, Garay S, Kuis W, Machado C, Pachman L, Prieur AM, Rider LG, Silverman E, Tsitsami E, Woo P, Giannini EH, Martini A; Paediatric Rheumatology International Trials Organization (PRINTO); Pediatric Rheumatology Collaborative Study Group (PRCSG). Ruperto N, et al. Among authors: feldman bm. Rheumatology (Oxford). 2003 Dec;42(12):1452-9. doi: 10.1093/rheumatology/keg403. Epub 2003 Jun 27. Rheumatology (Oxford). 2003. PMID: 12832713 Review.

7

Eye findings in patients with juvenile dermatomyositis.

Akikusa JD, Tennankore DK, Levin AV, Feldman BM. Akikusa JD, et al. Among authors: feldman bm. J Rheumatol. 2005 Oct;32(10):1986-91. J Rheumatol. 2005. PMID: 16206356

8

Long-term outcomes in juvenile dermatomyositis: how did we get here and where are we going?

Huber A, Feldman BM. Huber A, et al. Among authors: feldman bm. Curr Rheumatol Rep. 2005 Dec;7(6):441-6. doi: 10.1007/s11926-005-0048-1. Curr Rheumatol Rep. 2005. PMID: 16303103 Review.

9

Corticosteroid treatment of refractory Kawasaki disease.

Lang BA, Yeung RS, Oen KG, Malleson PN, Huber AM, Riley M, Ebbeson R, Ramsey SE, Laxer RM, Silverman ED, McCrindle BW, Ratnapalan S, Feldman BM. Lang BA, et al. Among authors: feldman bm. J Rheumatol. 2006 Apr;33(4):803-9. J Rheumatol. 2006. PMID: 16583481

10

Advances in the treatment of juvenile dermatomyositis.

Stringer E, Feldman BM. Stringer E, et al. Among authors: feldman bm. Curr Opin Rheumatol. 2006 Sep;18(5):503-6. doi: 10.1097/01.bor.0000240362.32089.4c. Curr Opin Rheumatol. 2006. PMID: 16896290

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

359 results

Search Page